Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Not all women diagnosed with PCOS share the same cardiovascular risk profiles.

Literature DB >> 19501355

Not all women diagnosed with PCOS share the same cardiovascular risk profiles.

Vuk P Jovanovic¹, Enrico Carmina, Rogerio A Lobo.

Abstract

Although definitive and confirmatory data are lacking, women with polycystic ovary syndrome (PCOS) are considered to be at increased risk for cardiovascular and metabolic disease. In recent years, the diagnosis of PCOS has broadened considerably to result in several phenotypes. Here we review the evidence for cardiovascular and metabolic risks in PCOS in the classic disorder and the various phenotypes. We conclude that not all women with PCOS should be considered as being similar in terms of cardiovascular risk profiles. Copyright (c) 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities: Disease Species

Mesh：

Year: 2009 PMID： 19501355 DOI： 10.1016/j.fertnstert.2009.04.021

Source DB: PubMed Journal: Fertil Steril ISSN： 0015-0282 Impact factor: 7.329

Keyword Cloud
Cited

17 in total

Review 1. Adverse Pregnancy Conditions, Infertility, and Future Cardiovascular Risk: Implications for Mother and Child.

Authors: Ki Park; Janet Wei; Margo Minissian; C Noel Bairey Merz; Carl J Pepine
Journal: Cardiovasc Drugs Ther Date: 2015-08 Impact factor: 3.727

Review 2. Targets to treat metabolic syndrome in polycystic ovary syndrome.

Authors: Shruthi Mahalingaiah; Evanthia Diamanti-Kandarakis
Journal: Expert Opin Ther Targets Date: 2015-10-21 Impact factor: 6.902

Review 3. Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis.

Authors: Michelle L Meyer; Angela M Malek; Robert A Wild; Mary T Korytkowski; Evelyn O Talbott
Journal: Hum Reprod Update Date: 2011-11-22 Impact factor: 15.610

4. Effect of metformin and flutamide on insulin, lipogenic and androgen-estrogen signaling, and cardiometabolic risk in a PCOS-prone metabolic syndrome rodent model.

Authors: M Kupreeva; A Diane; R Lehner; R Watts; M Ghosh; S Proctor; D Vine
Journal: Am J Physiol Endocrinol Metab Date: 2018-08-28 Impact factor: 4.310

5. Should all women with PCOS be treated for insulin resistance?

Authors: John C Marshall; Andrea Dunaif
Journal: Fertil Steril Date: 2012-01 Impact factor: 7.329

Review 6. A Narrative Review of Placental Contribution to Adverse Pregnancy Outcomes in Women With Polycystic Ovary Syndrome.

Authors: Angela S Kelley; Yolanda R Smith; Vasantha Padmanabhan
Journal: J Clin Endocrinol Metab Date: 2019-11-01 Impact factor: 5.958

Not all women diagnosed with PCOS share the same cardiovascular risk profiles.

Review 1. Adverse Pregnancy Conditions, Infertility, and Future Cardiovascular Risk: Implications for Mother and Child.

Review 2. Targets to treat metabolic syndrome in polycystic ovary syndrome.

Review 3. Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis.

4. Effect of metformin and flutamide on insulin, lipogenic and androgen-estrogen signaling, and cardiometabolic risk in a PCOS-prone metabolic syndrome rodent model.

5. Should all women with PCOS be treated for insulin resistance?

Review 6. A Narrative Review of Placental Contribution to Adverse Pregnancy Outcomes in Women With Polycystic Ovary Syndrome.

7. Relative contributions of oligomenorrhea and hyperandrogenemia to the risk of metabolic syndrome in midlife women.

Review 8. Androgens and Hypertension in Men and Women: a Unifying View.

Review 9. Oral contraceptives and cardiovascular risk in women with polycystic ovary syndrome.

Review 10. Complications and challenges associated with polycystic ovary syndrome: current perspectives.